Mediphase Venture Partners

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.

ImpactRx provides consultative and analytics-based promotional effectiveness solutions to the healthcare industry. The company tracks and evaluates the impact of pharmaceutical promotions on the prescribing behavior of physicians.

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.

Wellpartner is a nationally recognized provider of pharmacy distribution solutions for health plans, Medicaid programs, and safety net organizations throughout the country. Dedicated to lowering the cost of medications, we offer innovative approaches that improve pharmacy care for individuals through the use of retail contract pharmacy services. We are the largest independent provider of contract pharmacy program services in the nation.

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.

Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients. Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.

Wellpartner is a nationally recognized provider of pharmacy distribution solutions for health plans, Medicaid programs, and safety net organizations throughout the country. Dedicated to lowering the cost of medications, we offer innovative approaches that improve pharmacy care for individuals through the use of retail contract pharmacy services. We are the largest independent provider of contract pharmacy program services in the nation.

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.

PatientKeeper develops and delivers EHR optimization software. Our solutions streamline clinical and revenue cycle workflows for providers, care teams, billers, and coders to improve patient care and operational performance. With PatientKeeper as the system of engagement complementing the EHR system-of-record, providers can easily access and act on all their patient information from smartphones, tablets, and PCs.

Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients. Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.

Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients. Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.

Vitra Bioscience, a venture-backed biotechnology company, is developing novel technologies for comprehensive cellular analysis. The Company’s strategic objective is to create breakthrough solutions that enable users to acquire more informative data in less time, allowing for better decision-making. By applying modern imaging technology with proprietary consumables and software, Vitra Bioscience intends to develop and commercialize products that turn serial steps into parallel ones providing users with a complete tool set for their individual research needs.

PatientKeeper develops and delivers EHR optimization software. Our solutions streamline clinical and revenue cycle workflows for providers, care teams, billers, and coders to improve patient care and operational performance. With PatientKeeper as the system of engagement complementing the EHR system-of-record, providers can easily access and act on all their patient information from smartphones, tablets, and PCs.

Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients. Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.

ImpactRx provides consultative and analytics-based promotional effectiveness solutions to the healthcare industry. The company tracks and evaluates the impact of pharmaceutical promotions on the prescribing behavior of physicians.

Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients. Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.

PatientKeeper develops and delivers EHR optimization software. Our solutions streamline clinical and revenue cycle workflows for providers, care teams, billers, and coders to improve patient care and operational performance. With PatientKeeper as the system of engagement complementing the EHR system-of-record, providers can easily access and act on all their patient information from smartphones, tablets, and PCs.